Streamline Health Solutions, Inc. (STRM)
USD 3.45
(-5.48%)
USD 3.45
(-5.48%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.37 Million USD | 134.08% |
| 2022 | 3.15 Million USD | 1130.86% |
| 2021 | 256 Thousand USD | -17.95% |
| 2020 | 312 Thousand USD | -85.66% |
| 2019 | 2.17 Million USD | 38.42% |
| 2018 | 1.57 Million USD | 929.93% |
| 2017 | 152.63 Thousand USD | -51.7% |
| 2016 | 316.01 Thousand USD | 208.24% |
| 2015 | -291.94 Thousand USD | -105.63% |
| 2014 | 5.18 Million USD | 160.72% |
| 2013 | -8.53 Million USD | -235.8% |
| 2012 | 6.28 Million USD | 27.67% |
| 2011 | 4.92 Million USD | 24342.51% |
| 2010 | -20.31 Thousand USD | -107.11% |
| 2009 | 285.8 Thousand USD | 112.27% |
| 2008 | -2.32 Million USD | -6.39% |
| 2007 | -2.18 Million USD | -0.9% |
| 2006 | -2.16 Million USD | 9.68% |
| 2005 | -2.4 Million USD | -19.34% |
| 2004 | -2.01 Million USD | 58.4% |
| 2003 | -4.83 Million USD | -32.65% |
| 2002 | -3.64 Million USD | -27.32% |
| 2001 | -2.86 Million USD | -12.37% |
| 2000 | -2.54 Million USD | -234.2% |
| 1999 | 1.9 Million USD | 216.67% |
| 1998 | 600 Thousand USD | 128.57% |
| 1997 | -2.1 Million USD | -250.0% |
| 1996 | -600 Thousand USD | -200.0% |
| 1995 | 600 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 8.44 Million USD | 14.52% |
| 2024 Q2 | 8.92 Million USD | 5.69% |
| 2023 Q1 | 3.63 Million USD | 15.2% |
| 2023 Q3 | 7.23 Million USD | 33.24% |
| 2023 Q2 | 5.43 Million USD | 49.59% |
| 2023 Q4 | 7.37 Million USD | 1.95% |
| 2023 FY | 7.37 Million USD | 134.08% |
| 2022 FY | 3.15 Million USD | 1130.86% |
| 2022 Q3 | -1.77 Million USD | -142.58% |
| 2022 Q2 | 4.16 Million USD | 93.05% |
| 2022 Q1 | 2.15 Million USD | 742.58% |
| 2022 Q4 | 3.15 Million USD | 277.72% |
| 2021 FY | 256 Thousand USD | -17.95% |
| 2021 Q4 | 256 Thousand USD | 206.22% |
| 2021 Q1 | -14.05 Million USD | -4603.53% |
| 2021 Q2 | -15.51 Million USD | -10.43% |
| 2021 Q3 | -241 Thousand USD | 98.45% |
| 2020 FY | 312 Thousand USD | -85.66% |
| 2020 Q4 | 312 Thousand USD | 215.99% |
| 2020 Q3 | -269 Thousand USD | 90.73% |
| 2020 Q2 | -2.9 Million USD | 22.17% |
| 2020 Q1 | -3.73 Million USD | -271.42% |
| 2019 Q1 | 1.8 Million USD | 14.69% |
| 2019 Q4 | 2.17 Million USD | -3.37% |
| 2019 Q2 | 3.44 Million USD | 91.29% |
| 2019 FY | 2.17 Million USD | 38.42% |
| 2019 Q3 | 2.25 Million USD | -34.71% |
| 2018 Q3 | 2.95 Million USD | 199.24% |
| 2018 Q1 | 876.22 Thousand USD | 474.08% |
| 2018 FY | 1.57 Million USD | 929.93% |
| 2018 Q2 | 988.91 Thousand USD | 12.86% |
| 2018 Q4 | 1.57 Million USD | -46.88% |
| 2017 Q1 | 2.19 Million USD | 596.17% |
| 2017 Q3 | 3.03 Million USD | 39.06% |
| 2017 Q2 | 2.17 Million USD | -0.92% |
| 2017 Q4 | 152.63 Thousand USD | -94.96% |
| 2017 FY | 152.63 Thousand USD | -51.7% |
| 2016 Q3 | 4.01 Million USD | 1141.23% |
| 2016 Q1 | 2.43 Million USD | 935.23% |
| 2016 Q2 | 323.15 Thousand USD | -86.75% |
| 2016 Q4 | 316.01 Thousand USD | -92.12% |
| 2016 FY | 316.01 Thousand USD | 208.24% |
| 2015 Q4 | -291.94 Thousand USD | -120.76% |
| 2015 Q1 | 6.12 Million USD | 18.11% |
| 2015 Q2 | 4.29 Million USD | -29.78% |
| 2015 Q3 | 1.4 Million USD | -67.3% |
| 2015 FY | -291.94 Thousand USD | -105.63% |
| 2014 Q2 | 4.68 Million USD | 123.51% |
| 2014 Q1 | 2.09 Million USD | 124.53% |
| 2014 FY | 5.18 Million USD | 160.72% |
| 2014 Q3 | 3.54 Million USD | -24.25% |
| 2014 Q4 | 5.18 Million USD | 46.21% |
| 2013 FY | -8.53 Million USD | -235.8% |
| 2013 Q4 | -8.53 Million USD | -199.66% |
| 2013 Q1 | 9.4 Million USD | 49.61% |
| 2013 Q3 | 8.56 Million USD | 10.03% |
| 2013 Q2 | 7.78 Million USD | -17.22% |
| 2012 FY | 6.28 Million USD | 27.67% |
| 2012 Q2 | 48.47 Thousand USD | -98.8% |
| 2012 Q1 | 4.03 Million USD | -18.15% |
| 2012 Q4 | 6.28 Million USD | -14.45% |
| 2012 Q3 | 7.34 Million USD | 15058.68% |
| 2011 FY | 4.92 Million USD | 24342.51% |
| 2011 Q4 | 4.92 Million USD | 222.31% |
| 2011 Q2 | 858.87 Thousand USD | -28.92% |
| 2011 Q1 | 1.2 Million USD | 6048.85% |
| 2011 Q3 | 1.52 Million USD | 77.88% |
| 2010 Q3 | 1.96 Million USD | 12.63% |
| 2010 Q1 | 862.86 Thousand USD | 201.91% |
| 2010 FY | -20.31 Thousand USD | -107.11% |
| 2010 Q2 | 1.74 Million USD | 102.48% |
| 2010 Q4 | -20.31 Thousand USD | -101.03% |
| 2009 Q2 | -741.7 Thousand USD | -140.29% |
| 2009 Q1 | -308.67 Thousand USD | 86.75% |
| 2009 FY | 285.8 Thousand USD | 112.27% |
| 2009 Q3 | 1.1 Million USD | 249.25% |
| 2009 Q4 | 285.8 Thousand USD | -74.18% |
| 2008 Q2 | -372.69 Thousand USD | 70.09% |
| 2008 Q4 | -2.32 Million USD | -453.06% |
| 2008 FY | -2.32 Million USD | -6.39% |
| 2008 Q1 | -1.24 Million USD | 43.07% |
| 2008 Q3 | 659.6 Thousand USD | 276.98% |
| 2007 Q2 | -509.11 Thousand USD | 18.43% |
| 2007 Q3 | -628.66 Thousand USD | -23.48% |
| 2007 Q4 | -2.18 Million USD | -248.2% |
| 2007 FY | -2.18 Million USD | -0.9% |
| 2007 Q1 | -624.11 Thousand USD | 71.23% |
| 2006 Q4 | -2.16 Million USD | -360.25% |
| 2006 Q3 | -471.38 Thousand USD | 38.84% |
| 2006 Q2 | -770.73 Thousand USD | 22.39% |
| 2006 Q1 | -993.08 Thousand USD | 58.66% |
| 2006 FY | -2.16 Million USD | 9.68% |
| 2005 Q2 | -1.87 Million USD | -312.12% |
| 2005 Q1 | -455.69 Thousand USD | 77.36% |
| 2005 Q3 | -1.04 Million USD | 44.11% |
| 2005 FY | -2.4 Million USD | -19.34% |
| 2005 Q4 | -2.4 Million USD | -128.86% |
| 2004 FY | -2.01 Million USD | 58.4% |
| 2004 Q4 | -2.01 Million USD | -1479.15% |
| 2004 Q3 | -127.47 Thousand USD | 83.2% |
| 2004 Q2 | -758.6 Thousand USD | 79.37% |
| 2004 Q1 | -3.67 Million USD | 24.02% |
| 2003 FY | -4.83 Million USD | -32.65% |
| 2003 Q4 | -4.83 Million USD | -72.22% |
| 2003 Q3 | -2.8 Million USD | 13.31% |
| 2003 Q2 | -3.24 Million USD | -56.04% |
| 2003 Q1 | -2.07 Million USD | 43.06% |
| 2002 Q1 | -2.39 Million USD | 16.24% |
| 2002 Q3 | -2.11 Million USD | -19.7% |
| 2002 FY | -3.64 Million USD | -27.32% |
| 2002 Q2 | -1.76 Million USD | 26.43% |
| 2002 Q4 | -3.64 Million USD | -72.6% |
| 2001 Q2 | -2.13 Million USD | -1.17% |
| 2001 FY | -2.86 Million USD | -12.37% |
| 2001 Q1 | -2.1 Million USD | 17.33% |
| 2001 Q3 | -2.42 Million USD | -13.5% |
| 2001 Q4 | -2.86 Million USD | -18.37% |
| 2000 FY | -2.54 Million USD | -234.2% |
| 2000 Q2 | -1.92 Million USD | 24.61% |
| 2000 Q4 | -2.54 Million USD | -30.96% |
| 2000 Q3 | -1.94 Million USD | -1.27% |
| 2000 Q1 | -2.55 Million USD | -234.22% |
| 1999 Q4 | 1.9 Million USD | 90.0% |
| 1999 FY | 1.9 Million USD | 216.67% |
| 1999 Q3 | 1 Million USD | -50.0% |
| 1999 Q1 | 1.9 Million USD | 216.67% |
| 1999 Q2 | 2 Million USD | 5.26% |
| 1998 FY | 600 Thousand USD | 128.57% |
| 1998 Q1 | -1.6 Million USD | 23.81% |
| 1998 Q4 | 600 Thousand USD | -86.96% |
| 1998 Q3 | 4.6 Million USD | -4.17% |
| 1998 Q2 | 4.8 Million USD | 400.0% |
| 1997 FY | -2.1 Million USD | -250.0% |
| 1997 Q2 | - USD | 100.0% |
| 1997 Q3 | -700 Thousand USD | 0.0% |
| 1997 Q4 | -2.1 Million USD | -200.0% |
| 1997 Q1 | -1 Million USD | -66.67% |
| 1996 Q2 | -31.8 Million USD | 6.47% |
| 1996 FY | -600 Thousand USD | -200.0% |
| 1996 Q4 | -600 Thousand USD | 97.95% |
| 1996 Q1 | -34 Million USD | -5766.67% |
| 1996 Q3 | -29.3 Million USD | 7.86% |
| 1995 FY | 600 Thousand USD | 0.0% |
| 1995 Q4 | 600 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | 99.046% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 99.9% |
| Sharecare, Inc. | -125.84 Million USD | 105.861% |
| Progyny, Inc. | -77.9 Million USD | 109.468% |
| Aclarion, Inc. | 94.65 Thousand USD | -7692.51% |
| CareMax, Inc. | 426.4 Million USD | 98.27% |
| Simulations Plus, Inc. | -9.83 Million USD | 174.99% |
| CareCloud, Inc. | 11.4 Million USD | 35.31% |
| Forian Inc. | 16.95 Million USD | 56.506% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 381.019% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 381.019% |
| Minerva Surgical, Inc. | 32.74 Million USD | 77.476% |
| Omnicell, Inc. | 113.11 Million USD | 93.479% |
| Definitive Healthcare Corp. | 136.95 Million USD | 94.614% |
| Zhongchao Inc. | -6.74 Million USD | 209.427% |
| Accolade, Inc. | 55.93 Million USD | 86.812% |
| Ontrak, Inc. | -8.01 Million USD | 192.062% |
| SOPHiA GENETICS SA | -104.65 Million USD | 107.048% |
| R1 RCM Inc. | 1.56 Billion USD | 99.529% |
| Spok Holdings, Inc. | -20.9 Million USD | 135.287% |
| Privia Health Group, Inc. | -381.22 Million USD | 101.935% |
| EUDA Health Holdings Limited | 3.18 Million USD | -131.548% |
| HeartBeam, Inc. | -16.18 Million USD | 145.562% |
| GeneDx Holdings Corp. | 20.08 Million USD | 63.283% |
| TruBridge, Inc. | 199.44 Million USD | 96.302% |
| Nutex Health, Inc. | 253.75 Million USD | 97.093% |
| Renalytix Plc | 3.85 Million USD | -91.336% |
| Sharecare, Inc. | -125.84 Million USD | 105.861% |
| Health Catalyst, Inc. | 142.79 Million USD | 94.834% |
| 10x Genomics, Inc. | -263.91 Million USD | 102.795% |
| GoodRx Holdings, Inc. | 38.77 Million USD | 80.977% |
| SCWorx Corp. | -1077.00 USD | 684965.367% |
| Schrödinger, Inc. | -33.18 Million USD | 122.228% |
| HealthEquity, Inc. | 529.16 Million USD | 98.606% |
| HealthStream, Inc. | -17.11 Million USD | 143.104% |
| MSP Recovery, Inc. | 667.69 Million USD | 98.895% |
| Augmedix, Inc. | -20.49 Million USD | 135.988% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 99.798% |
| Ontrak, Inc. | -8.01 Million USD | 192.062% |
| SHL Telemedicine Ltd. | 13.15 Million USD | 43.943% |
| CareCloud, Inc. | 11.4 Million USD | 35.31% |
| Premier, Inc. | 855 Thousand USD | -762.69% |
| Certara, Inc. | 63.24 Million USD | 88.337% |
| GeneDx Holdings Corp. | 20.08 Million USD | 63.283% |
| OneMedNet Corporation | 5.05 Million USD | -45.935% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 99.798% |
| EUDA Health Holdings Limited | 3.18 Million USD | -131.548% |
| HeartBeam, Inc. | -16.18 Million USD | 145.562% |
| CareCloud, Inc. | 11.4 Million USD | 35.31% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | 1308.53% |
| CareMax, Inc. | 426.4 Million USD | 98.27% |
| Healthcare Triangle, Inc. | 3.08 Million USD | -139.247% |
| National Research Corporation | 32.3 Million USD | 77.166% |
| Aclarion, Inc. | 94.65 Thousand USD | -7692.51% |
| OptimizeRx Corporation | 22.97 Million USD | 67.89% |